{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-115270","form_type":"8-K","ticker":null,"cik":"0000850261","company_name":"Sorrento Therapeutics, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.150456+00:00","generated_at":"2026-06-08T18:28:13.632988+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CFO Elizabeth Czerepak terminated; Sorrento cuts US workforce from 123 to 90","bullets":["On Nov 3, 2023, Sorrento terminated Elizabeth Czerepak as EVP and CFO, effective immediately.","US headcount reduced from 123 to 90 employees, a 27% cut.","No replacement CFO has been announced; CRO Mohsin Meghji signed the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-115270","json":"https://secwatch.observer/filing/0001104659-23-115270.json","markdown":"https://secwatch.observer/filing/0001104659-23-115270.md","text":"https://secwatch.observer/filing/0001104659-23-115270.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/0001104659-23-115270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/tm2330125d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T18:28:13.632988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d8d7dd0d06","claim":"Elizabeth Czerepak was terminated as Executive Vice President and Chief Financial Officer at Sorrento Therapeutics, Inc..","evidence_excerpt":"On November 3, 2023, in connection with the reduction in headcount described below, Sorrento Therapeutics, Inc. (“ Sorrento ” or the “ Company ”) terminated the employment of Elizabeth Czerepak as its Executive Vice President and Chief Financial Officer effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/850261/000110465923115270/0001104659-23-115270-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}